Shares of Aurinia Pharmaceuticals Inc. (AUPH) are surging more than 15% in pre-market trade on Friday at $10.59.
Thursday, the company's Board revealed that it has started exploring strategic alternatives including a sale or merger of the company, among others.
JP Morgan is acting as the financial advisor in the process, the company said.
On Thursday, AUPH closed at $9.16, down 0.22%. It has traded in the range of $4.07 - $12.60 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.